Cardiac toxicity from Sunitinib and sorafenib
Posted: Mon Nov 17, 2008 12:16 pm
Cardiac damage from tyrosine kinase inhibitors (TKI) Sunitinib and sorafenib
http://jco.ascopubs.org/cgi/content/abstract/26/32/5204
Cardiac damage from TKI treatment is a largely underestimated phenomenon but is manageable if patients have careful cardiovascular monitoring and cardiac treatment at the first signs of myocardial damage.
http://jco.ascopubs.org/cgi/content/abstract/26/32/5204
Cardiac damage from TKI treatment is a largely underestimated phenomenon but is manageable if patients have careful cardiovascular monitoring and cardiac treatment at the first signs of myocardial damage.